Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Oppenheimer analyst Kristen Owen maintained a Buy rating on CNH Industrial (CNH – Research Report) today and set a price target of $16.00. The ...

Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...

Real’s first book, “I Don’t Want to Talk About It: Overcoming the Secret Legacy of Male Depression,” is an extended ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...

HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading food distributor to Asian restaurants across the United States, announced today that the Company will be participating ...

We recently compiled a list of the 12 Biggest Lithium Stocks to Buy According to Hedge Funds. In this article, we are going ...

Oppenheimer analysts adjusted their outlook on Ingredion stock (NYSE: NYSE:INGR), reducing the price target from $178.00 to $167.00, while maintaining an Outperform rating. The modification follows a ...

It’s a terrific movie, historically accurate and thought-provoking. The film’s recurring theme is Oppenheimer’s nightmarish ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.